---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-138428"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2024-12-19T23:59:59+00:00"
generated_at: "2026-05-29T01:46:03.010881+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical faces derivative lawsuit over alleged false FDA approval statements

## Summary
- Filed Dec 13, 2024 in US District Court for Colorado by shareholder Jose Lazo.
- Defendants include CEO Eric Schlorff, former CFO, and certain current/former directors.
- Alleges false/misleading statements about FDA prospects for Selective Cytopheretic Device and deficient internal controls.
- Claims violations of Exchange Act Sections 14(a), 10(b), 21D, plus breach of fiduciary duty and unjust enrichment.
- Seeks damages, restitution, and injunctive relief; substantially similar to a prior class action disclosed July 2024.

## SEC filing metadata
- accession: 0000950170-24-138428
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2024-12-19T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000095017024138428/0000950170-24-138428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000095017024138428/icu-20241213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-138428
- JSON: https://secwatch.observer/filing/0000950170-24-138428.json
- Plain text: https://secwatch.observer/filing/0000950170-24-138428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.